Ario Pharma's Seed VC Round

Ario Pharma raised a round of funding on December 12, 2013.

Ario pharma focusses on the development of drugs for the treatment of respiratory indications. Ario is about to evaluate the anti-tussive properties of XEN-D0501, a potential best-in-class TRPV1 inhib…

Articles about Ario Pharma's Seed VC Round: